Vitamin D Therapy Market: Global Industry Forecast (2022-2027) by Route of administration, Age Group, Purchase Pattern, Application, and Region

Vitamin D Therapy Market size was valued at US$ 1.11 Bn. in 2021 and the total Vitamin D Therapy revenue is expected to grow at 12.2 % through 2022 to 2027, reaching nearly US$ 2.21 Bn.

Vitamin D Therapy Market Overview:

Vitamin D is also known as the "sunshine vitamin" because the human body produces it from cholesterol when exposed to sunlight. Vitamin D assists in calcium and phosphorous absorption from the small intestine and regulates the release of parathyroid hormones, which can cause bone resorption. The prevalent most common causes of Vitamin D deficiency include a lack of exposure to sunshine, a loss of ability to absorb Vitamin D, and vitamin D not being absorbed owing to liver or kidney disease. Vitamin D treatment has various medicinal applications and is used to treat many diseases such as osteoporosis, rickets, skin problems, muscular weakness, autoimmune disorders, and so on. All of these diseases are often caused by a lack of Vitamin D and may be addressed with Vitamin D therapy, which results in healthier skin and stronger bones because it helps in the absorption of calcium. However, vitamin D therapy treatments are widely utilized for the treatment of osteoporosis because it is common in older people, who are more prone to fractures due to high levels of parathyroid hormones. Vitamin D Therapy Market To know about the Research Methodology:-Request Free Sample Report In this report, the Vitamin D Therapy market's growth reasons, as well as the market's many segments (Route of administration, Age Group, Purchase Pattern, Application, and, Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Vitamin D Therapy market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Vitamin D Therapy market situation.

Vitamin D Therapy Market Dynamics:

Vitamin D Concern across the world boosting the market growth In the recent decade, there has been widespread concern about vitamin D status in the health and biomedical fields, and several research initiatives have been undertaken to investigate its advantages, usage, and deficiency. Vitamin D deficiency is a global health concern that affects both children and adults and is considered an epidemic. The Middle East and North African region, which includes Saudi Arabia have a relatively high rate of vitamin D deficiency, reaching 82% across all age groups. Increased awareness of vitamin D deficiencies across the world is a key element affecting the market. Furthermore, an increase in healthcare expenditure would assist the growth of the sector during the forecast period. Health Awareness programs and healthcare expenditure are provided by government authorities across the globe The National Institutes of Health (NIH) Office of Dietary Supplements (ODS) sponsored and financed various programs to enhance scientific understanding of the importance of vitamin D to health. Furthermore, Increased research & development to increase the uses of vitamin D treatment is expected to help the market acquire traction in the coming years. The United States Food and Drug Administration recently approved a rise in the quantity of vitamin D that may be added as an optional ingredient to milk, as well as the addition of vitamin D to beverages made from edible plants intended as milk alternatives, such as soy, almond, and coconut beverages, and edible plant-based yogurt alternatives. Vitamin D was always permitted in soy drinks, but today's approval raises the permitted dosage for such beverages intended as milk substitutes. Increasing osteoporosis among people drives the market growth during the forecast period Over 200 Billion people worldwide are estimated to have osteoporosis. The frequency of osteoporosis is growing as the senior population becomes older. Approx number of osteoporotic fractures in the European Union was estimated to be 6.7 Billion in 2020. Osteoporosis can be controlled by Vitamin D therapy. Thus, the market for vitamin D therapy is increased during the forecast period. Vitamin D Therapy Market Restraint for the Vitamin D therapy market Overdoes of vitamin D can cause weakness, dry mouth, nausea, vomiting, and other negative effects. Taking vitamin D in doses of more than 4000 IU (100 mcg) daily over an extended length of time is potentially dangerous and may result in extremely high calcium levels in the blood. which is harmful to the heart, blood vessels, and kidneys. Therefore, people fill the deficiency of vitamin D naturally via exposure to sunlight and consumption of fortified foods. Because of this reason market for Vitamin D therapy may hamper during the forecast period.

Vitamin D Therapy Market Segment Analysis:

By Route of administration, the oral route segment is likely to fuel the growth of the vitamin D therapy market during the forecast period. This is due to the ease of ingestion, improved pharmacokinetic and pharmacodynamic performance, less toxicity risk, enhanced patient tolerance, and a preference for the oral route. The oral route is the most frequent and approved route for medication. It is the easiest, most convenient, and safest method. it is painless and the patient can be taken as tablets or can be mixed with food. By Application, the osteoporosis segment is expected to grow at the highest CAGR rate of xx % during the forecast period. This surge can be attributed to the higher occurrence of falls and fractures in senior citizens as a result of raised thyroid hormone levels and insufficient calcium absorption from their diets. By Age Group, Senior Adults face more bone problems as compared to others. Vitamin D is essential for senior adults' health and well-being. Despite the universal need for Vitamin D, many older people across the world are vitamin D deficient. They require Vitamin D to help their bodies absorb calcium. Without this nutrient, bones can become brittle, thin, and deformed. Vitamin D, when combined with calcium it helps to prevent seniors from osteoporosis. Vitamin D Therapy Market

Vitamin D Therapy Market Regional Insights:

The Asia-Pacific region holds the largest market share in the Global Vitamin D Therapy Market. The demand for Vitamin D therapy is high in this region owing to the large population, and more investments in healthcare facilities in this region. In this region, a large proportion of the population is old or has an unhealthy life, which makes them prone to Vitamin D deficiency. Furthermore, many governments are now publishing policies in these regions to raise awareness of Vitamin D deficiency and its remedies. Therefore, the market is expected to grow at the fastest rate in this region over the forecast period. North America has been witnessing a positive Vitamin D therapy market throughout the forecasted period followed by Europe due to the global leaders in R&D activities, vulnerable osteoporosis population, and presence of refined healthcare facilities in this region. The objective of the report is to present a comprehensive analysis of the Vitamin D Therapy market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Vitamin D Therapy market dynamics, and structure by analyzing the market segments and projecting the Vitamin D Therapy market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Vitamin D Therapy market make the report investor’s guide.

Vitamin D Therapy Market Scope: Inquire before buying

Global Vitamin D Therapy Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.11 Bn
Forecast Period 2022 to 2027 CAGR: 12.2 % Market Size in 2027: US $ 2.21 Bn.
Segments Covered: by Route of Administration • Oral Route • Parenteral Route
by Purchasing Pattern • OTC Drugs • Prescription Drugs
by Application • Osteoporosis • Rickets • Skin Diseases • Muscle Weakness • Autoimmune Disorders • Other Applications
by Age Group • Children • Adults • Senior Adults

Vitamin D Therapy Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Vitamin D Therapy Market Key Players

Pfizer Inc • GlaxoSmithKline PLC • Novartis AG • Merck & Co., Inc. • Abbott • Sanofi • Alkem Laboratories Ltd. • Cadila Healthcare Ltd. • Sun Pharmaceutical Industries Ltd. • Torrent Pharmaceuticals Ltd. • Ortho Molecular Products Inc. • Biotics Research Corporation • Novartis AG • Zudus Cadila • Solvay Pharma India Pvt. Ltd. • Forgo Pharmaceuticals Ltd. • Mankind Pharmaceuticals Pvt. Ltd. • Cipla Ltd • Stanley Healthcare • Win Medicare Ltd. FAQs: 1. Which is the potential market for Vitamin D Therapy in terms of the region? Ans. In the APAC region, the large population, and more investments in healthcare facilities are expected to drive the market. 2. What is expected to drive the growth of the Vitamin D Therapy market in the forecast period? Ans. Awareness programs and healthcare expenditure by the government authorities across the globe. 3. What is the projected market size & growth rate of the Vitamin D Therapy Market? Ans. Vitamin D Therapy Market size was valued at US$ 1.11 Bn. in 2021 and the total Vitamin D Therapy revenue is expected to grow at xx% through 2022 to 2027, reaching nearly US$ 2.21 Bn. 4. What segments are covered in the Vitamin D Therapy Market report? Ans. The segments covered are Route of administration, Age Group, Purchase Pattern, Application, and Region.
1. Global Vitamin D Therapy Market: Research Methodology 2. Global Vitamin D Therapy Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Vitamin D Therapy Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Vitamin D Therapy Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Vitamin D Therapy Market Segmentation 4.1 Global Vitamin D Therapy Market, by Route of Administration (2022-2027) • Oral Route • Parenteral Route 4.2 Global Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) • OTC Drugs • Prescription Drugs 4.3 Global Vitamin D Therapy Market, by Application (2022-2027) • Osteoporosis • Rickets • Skin Diseases • Muscle Weakness • Autoimmune Disorders • Other Applications 4.4 Global Vitamin D Therapy Market, by Age Group (2022-2027) • Children • Adults • Senior Adults 5. North America Vitamin D Therapy Market(2022-2027) 5.1 North America Vitamin D Therapy Market, by Route of Administration (2022-2027) • Oral Route • Parenteral Route 5.2 North America Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) • OTC Drugs • Prescription Drug 5.3 North America Vitamin D Therapy Market, by Application (2022-2027) • Osteoporosis • Rickets • Skin Diseases • Muscle Weakness • Autoimmune Disorders • Other Applications 5.4 North America Vitamin D Therapy Market, by Age Group (2022-2027) • Children • Adults • Senior Adults 5.5 North America Vitamin D Therapy Market, by Country (2022-2027) • United States • Canada • Mexico 6. Europe Vitamin D Therapy Market (2022-2027) 6.1. European Vitamin D Therapy Market, by Route of Administration (2022-2027) 6.2. European Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) 6.3. European Vitamin D Therapy Market, by Application (2022-2027) 6.4. European Vitamin D Therapy Market, by Age Group (2022-2027) 6.5. European Vitamin D Therapy Market, by Country (2022-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Vitamin D Therapy Market (2022-2027) 7.1. Asia Pacific Vitamin D Therapy Market, by Route of Administration (2022-2027) 7.2. Asia Pacific Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) 7.3. Asia Pacific Vitamin D Therapy Market, by Application (2022-2027) 7.4. Asia Pacific Vitamin D Therapy Market, by Age Group (2022-2027) 7.5. Asia Pacific Vitamin D Therapy Market, by Country (2022-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Vitamin D Therapy Market (2022-2027) 8.1 Middle East and Africa Vitamin D Therapy Market, by Route of Administration (2022-2027) 8.2. Middle East and Africa Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) 8.3. Middle East and Africa Vitamin D Therapy Market, by Application (2022-2027) 8.4. Middle East and Africa Vitamin D Therapy Market, by Age Group (2022-2027) 8.5. Middle East and Africa Vitamin D Therapy Market, by Country (2022-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Vitamin D Therapy Market (2022-2027) 9.1. South America Vitamin D Therapy Market, by Route of Administration (2022-2027) 9.2. South America Vitamin D Therapy Market, by Purchasing Pattern (2022-2027) 9.3. South America Vitamin D Therapy Market, by Application (2022-2027) 9.4. South America Vitamin D Therapy Market, by Age Group (2022-2027) 9.5. South America Vitamin D Therapy Market, by Country (2022-2027) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Pfizer Inc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 GlaxoSmithKline PLC 10.3 Novartis AG 10.4 Merck & Co., Inc. 10.5 Abbott 10.6 Sanofi 10.7 Alkem Laboratories Ltd. 10.8 Cadila Healthcare Ltd. 10.9 Sun Pharmaceutical Industries Ltd. 10.10 Torrent Pharmaceuticals Ltd. 10.11 Ortho Molecular Products Inc. 10.12 Biotics Research Corporation 10.13 Novartis AG 10.14 Zudus Cadila 10.15 Solvay Pharma India Pvt. Ltd. 10.16 Forgo Pharmaceuticals Ltd. 10.17 Mankind Pharmaceuticals Pvt. Ltd. 10.18 Cipla Ltd 10.19 Stanley Healthcare 10.20 Win Medicare Ltd.

About This Report

Report ID 29834
Category Healthcare
Published Date May 2019
Updated Date June 2022
Contact Us